You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Innate Pharma SA said AstraZeneca updated the expected high-level PACIFIC-9 Phase 3 trial data readout to the first half of 2027 from the second half of 2026, reflecting the study’s event-driven nature.
Innate Pharma SA announced executive participation in the Stifel Healthcare Conference in New York, United States, on November 10–12, 2026, and the Jefferies Global Healthcare Conference in London, United Kingdom, on November 16-19, 2026.
Innate Pharma SA will hold a conference call on Thursday, November 5, 2026, at 2 p.m. CET / 8 a.m. ET to provide a business and financial update for the third quarter of 2026.
